A traditional Chinese medicine YXQN reduces amyloid-induced cytotoxicity by inhibiting A β42 aggregation and fibril formation.

CONCLUSION: Based on these results, YXQN exerts a neuroprotective effect by inhibiting Aβ42 toxic aggregation, which has the potential to combat AD. PMID: 32031066 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32031066?dopt=Abstract

Source: Current Pharmaceutical Design - February 6, 2020 Category: Drugs & Pharmacology Authors: Wang L, Liu S, Xu J, Watanabe N, Di J, Wei W, Mayo KH, Li J, Li X Tags: Curr Pharm Des Source Type: research